Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02RAY
|
||||
| Former ID |
DNC013479
|
||||
| Drug Name |
GLAUCINE
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528616] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C21H25NO4
|
||||
| Canonical SMILES |
CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)OC)OC)OC
|
||||
| InChI |
1S/C21H25NO4/c1-22-7-6-12-9-18(25-4)21(26-5)20-14-11-17(24-3)16(23-2)10-13(14)8-15(22)19(12)20/h9-11,15H,6-8H2,1-5H3/t15-/m0/s1
|
||||
| InChIKey |
RUZIUYOSRDWYQF-HNNXBMFYSA-N
|
||||
| CAS Number |
CAS 475-81-0
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | D(2) dopamine receptor | Target Info | Inhibitor | [528616] | |
| Dopamine D1 receptor | Target Info | Inhibitor | [528616] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Dopamine receptor mediated signaling pathway | |||||
| Nicotine pharmacodynamics pathwayP05912:Dopamine receptor mediated signaling pathway | |||||
| PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.